J. Goldman & CO LP Jazz Pharmaceuticals PLC Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, J. Goldman & CO LP holds 18,969 shares of JAZZ stock, worth $2.3 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,969
Previous 76,885
75.33%
Holding current value
$2.3 Million
Previous $8.21 Million
74.24%
% of portfolio
0.07%
Previous 0.25%
Shares
9 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$745 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$740 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$302 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$254 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$236 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.6B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...